Corcept Therapeutics CORT
NASDAQ CORT
$75.03 +2.26 (+3.11%)
At close: Nov 9, 2026 · 4:00 PM EST

Corcept Therapeutics (CORT) Operating Income (2010 - 2026)

Updated

Corcept Therapeutics (CORT) reported Operating Income of $114.72 million for Q3 2026, compared with $10.22 million a year earlier and up 177.8% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Operating Income (2010 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Corcept Therapeutics' Operating Income came in at $110.91 million, up 69.1% year-over-year; for FY2025, it was $44.8 million, down 67.3% from FY2024.

  • Operating Income has a five-year compound annual growth rate of -19.0% (FY2020 to FY2025).
  • By year, Operating Income came in at $136.95 million in FY2024 (+27.7%), $107.28 million in FY2023 (-4.8%), $112.63 million in FY2022 (-9.5%) and $124.48 million in FY2021 (-2.9%).
  • The Q3 2026 figure ranks as the highest quarterly Operating Income in data going back to Q2 2010.
  • Year over year, Operating Income gained in 1 of the last six quarters, with an average decline of 39.9%.
  • The high point for year-over-year Operating Income in five years was Q1 2024 (growth of 98.6%); the low point was Q1 2025 (a decline of 88.4%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $41.3 million (Q2 2026), -$49.6 million (Q1 2026) and $4.49 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 12.79 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 6.18 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 6.27 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.59 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 4.39 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 3.46 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 5.47 Bn
10 Corcept Therapeutics 7.99 Bn 6.60 Bn 335.86 Mn 114.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 114.72 Mn
Jun 30, 2026 41.30 Mn
Mar 31, 2026 -49.60 Mn
Dec 31, 2025 4.49 Mn
Sep 30, 2025 10.22 Mn
Jun 30, 2025 26.68 Mn
Mar 31, 2025 3.42 Mn
Dec 31, 2024 25.26 Mn
Sep 30, 2024 46.60 Mn
Jun 30, 2024 35.59 Mn
Mar 31, 2024 29.50 Mn
Dec 31, 2023 31.67 Mn
Sep 30, 2023 31.18 Mn
Jun 30, 2023 29.58 Mn
Mar 31, 2023 14.85 Mn
Dec 31, 2022 22.50 Mn
Sep 30, 2022 31.93 Mn
Jun 30, 2022 31.43 Mn
Mar 31, 2022 26.77 Mn
Dec 31, 2021 36.66 Mn
API Access

Corcept Therapeutics Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=CORT&period=max&api_key=YOUR_API_KEY